200 related articles for article (PubMed ID: 12918149)
21. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
[TBL] [Abstract][Full Text] [Related]
22. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
23. Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease.
Cury J; Coelho RF; Srougi M
Sao Paulo Med J; 2008 Mar; 126(2):119-22. PubMed ID: 18553035
[TBL] [Abstract][Full Text] [Related]
24. Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: analysis of 388 biopsy-prostatectomy pairs.
Kryvenko ON; Diaz M; Meier FA; Ramineni M; Menon M; Gupta NS
Am J Clin Pathol; 2012 May; 137(5):739-46. PubMed ID: 22523212
[TBL] [Abstract][Full Text] [Related]
25. Prediction of extraprostatic extension in patients with clinically organ-confined prostate cancer.
Lin S; Zhang Q; Li P; Li Z; Sun Y; Shao Y; Zhang X; Fu S
Urol Int; 2014; 92(3):282-8. PubMed ID: 24280781
[TBL] [Abstract][Full Text] [Related]
26. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
[TBL] [Abstract][Full Text] [Related]
27. Correlation between prostate needle biopsies and radical prostatectomy specimens: can we predict pathological outcome?
Zam NA; Tan PH; Sim HG; Lau WK; Yip SK; Cheng CW
Pathology; 2008 Oct; 40(6):586-91. PubMed ID: 18752125
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of perineural invasion in patients who underwent radical prostatectomy for localized prostate cancer.
Dell'Atti L
J BUON; 2016; 21(5):1219-1223. PubMed ID: 27837626
[TBL] [Abstract][Full Text] [Related]
29. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.
Yoon GS; Wang W; Osunkoya AO; Lane Z; Partin AW; Epstein JI
J Urol; 2008 Jun; 179(6):2203-6; discussion 2206. PubMed ID: 18423736
[TBL] [Abstract][Full Text] [Related]
30. Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study.
Ishizaki F; Hara N; Koike H; Kawaguchi M; Tadokoro A; Takizawa I; Nishiyama T; Takahashi K; Hohenfellner R
Diagn Pathol; 2012 Jun; 7():68. PubMed ID: 22697234
[TBL] [Abstract][Full Text] [Related]
31. High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.
Chaux A; Fajardo DA; Gonzalez-Roibon N; Partin AW; Eisenberger M; DeWeese TL; Netto GJ
Urology; 2012 Apr; 79(4):863-8. PubMed ID: 22173174
[TBL] [Abstract][Full Text] [Related]
32. Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance.
Ramos N; Macedo A; Rosa J; Carvalho M
Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348961
[TBL] [Abstract][Full Text] [Related]
33. [Prostate cancer reporting: needle biopsy and radical prostatectomy specimen].
Tóth E; Salamon F
Magy Onkol; 2019 Mar; 63(1):10-15. PubMed ID: 30889616
[TBL] [Abstract][Full Text] [Related]
34. [Histopathology reports of findings of prostate needle biopsies. Individual treatment].
Damjanoski I; Müller J; Schnöller TJ; Küfer R; Rinnab L
Urologe A; 2013 Feb; 52(2):226-39. PubMed ID: 23064867
[TBL] [Abstract][Full Text] [Related]
35. Bilateral cancer in prostate biopsy associates with the presence of extracapsular disease and positive surgical margins in low risk patients: a consideration for bilateral nerve sparing radical prostatectomy decision.
Sfoungaristos S; Perimenis P
Urol J; 2013 Sep; 10(3):966-72. PubMed ID: 24078504
[TBL] [Abstract][Full Text] [Related]
36. 3+4 = 6? Implications of the stratification of localised Gleason 7 prostate cancer by number and percentage of positive biopsy cores in selecting patients for active surveillance.
Ruiz-Cerdá JL; Lorenzo Soriano L; Ramos-Soler D; Marzullo-Zucchet L; Loras Monfort A; Boronat Tormo F
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):103-113. PubMed ID: 28919101
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.
Grignon DJ
Mod Pathol; 2018 Jan; 31(S1):S96-109. PubMed ID: 29297497
[TBL] [Abstract][Full Text] [Related]
38. Predictive Factors for Gleason Score Upgrading in Patients with Prostate Cancer after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Wang Y; Chen X; Liu K; Liu R; Li L; Yin C; Song P
Urol Int; 2023; 107(5):460-479. PubMed ID: 36990065
[TBL] [Abstract][Full Text] [Related]
39. The association between perineural invasion in mpMRI-targeted and/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy.
Karsiyakali N; Bulent Ozgen M; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
Actas Urol Esp (Engl Ed); 2022; 46(6):377-384. PubMed ID: 35260369
[TBL] [Abstract][Full Text] [Related]
40. Perineural invasion on biopsy specimen as predictor of tumor progression in aging male treated with radical prostatectomy. Could we use it for pre-surgical screening?
Vukovic M; Kavaric P; Magdelinic A; Nikomanis P; Tomovic S; Pelicic D
Aging Male; 2020 Dec; 23(5):720-725. PubMed ID: 30843451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
